$234.76
7.443.27%
Last update: Nov 9, 7:43 AM
Jazz Pharmaceuticals PLC
JAZZNASDAQ
The average analyst price target for Jazz Pharmaceuticals is $266.44, 12.9% above the current price. Of 20 analysts, 18 rate it Buy and 2 Hold. Targets range from $150 to $337. The latest change came on Nov 3, 2026, when JP Morgan raised its price target on Jazz Pharmaceuticals from $300 to $310 and kept an Overweight rating.
Price Target Range — 9 Quarters
Analyst Consensus — 20 Analysts
Rating Trend — Last 9 Months
